Inscopix is pioneering a new paradigm in the quest to understand the brain and its diseases. Combining revolutionary technology and methods for the imaging of large-scale neural activity in a naturally behaving subject, Inscopix has developed the enabling means to relate causal neural circuit dynamics to corresponding behavior. With its flagship product, nVista HD, Inscopix is today disseminating these capabilities to neuroscientists across the world, empowering them to gather unprecedented data and to make new scientific discoveries. With strategic collaborators and partners, Inscopix is at the same time developing in vivo neuropsychiatric disease assays and stands on the brink of making fundamental breakthroughs on treatments for brain diseases such as autism and schizophrenia.
Inscopix spun-out of Stanford University in 2011. Inscopix's core technology and methods for in vivo brain imaging spawned out of almost a decade of interdisciplinary research conducted by Inscopix's founding team at Stanford and was first reported in Nature Methods and Nature Medicine (cover story). At the 2012 Society for Neuroscience Meeting, Inscopix launched nVista HD, an end-to-end solution that today permits neuroscientists to stream live, high-definition videos of large-scale neural activity from the brain of an awake, naturally behaving mouse.
Inscopix has a rock star team, is advised by academic and industry luminaries, and is backed by leading institutional investors.